CEO Today USA Awards

MISSOURI 75 www.ceotodaymagazine.com CEO Today USAAwards 2017 www.curiumpharma.com France; Petten in the Netherlands; and Maryland Heights, Missouri, in the US – all close to major transport links. Operating our own molybdenum processing facility alongside an impressive network of radiopharmaceutical manufacturing plants has enabled us to become the largest producer of the medical isotope molybdenum-99, and its derivative, technetium-99m, which is utilized in 80% of all nuclear medicine procedures. This gives us a unique position in the industry as a single company that has combined the processing, manufacture, and supply of radiopharmaceuticals. Alongside the development and manufacture of its products, Curium manages a sophisticated logistics network, using regional hubs, national and international couriers, and airlines—shipping products to customers around the clock. This vertical integration—bringing together multiple stages in the nuclear medicine supply chain— allows Curium to provide higher-quality services and better value to its customers. Compliance and reliability Curium’s mission is to improve the quality of care to sick patients by providing life-saving diagnosis and treatment which fulfils the passion, pride, ambition, and future of all our employees. It is a promise that we make to all patients, our customers, and also our employees through our commitment to setting new standards for customer service, product efficacy, and value. The company is dedicated to supplying hospitals and clinics with the highest standard of product so that doctors can diagnose and treat critically ill patients rapidly and efficiently. Three fundamental values drive every aspect of what we do: Commitment, Collaboration, and Integrity. We are deeply committed to finding new and better ways of developing and supplying products, working closely with our customers and suppliers, while ensuring that our business conduct is always honest and transparent. It is our exceptional service and industry dedication that enable us to build and foster long-term partnerships with our customers. Over the years, Curium has proven to be a reliable and trusted partner for our customers, one that contributes to their success and sustainability. As Curium grows, doctors and medical experts can continue to save more lives each year. Their success is our success. This is something for which we will continue to strive. Securing the future with growth Our phenomenal performance in the last year indicates that we are on a solid path to delivering growth — for ourselves, for our customers, and for our investors. We continue to look for growth opportunities to maximize profitability and offer the best value for customers and the patients we serve, while continuously being the example by which others are measured. Curium continues to pursue growth through ongoing investment and focus in research and development and strategic acquisition opportunities, to expand our product portfolio and release more potentially life-saving nuclear medicine diagnostic and therapeutic solutions. The services Curium provides will become increasingly important as the world population grows, life expectancy rises, and disease rates increase. As experts predict the demand for radiopharmaceuticals will grow hugely in the coming years, Curium will be best placed to supply high-quality products and services, enabling a better future for all. WHAT IS NUCLEAR MEDICINE? Nuclear medicine is an area of medicine where special cameras are used to track the paths of radioactive tracers as they travel through the body. The tracers are injected into the bloodstream, inhaled or swallowed. As the radioactive tracers move through the areas being examined, they give off energy in the form of gamma rays or positrons. This energy is detected by the camera, and then a computer creates a 3D image of the inside of the body. Nuclear medicine plays a critical role in diagnosing patient disease. It is a cost-effective, non-invasive procedure that helps to diagnose disease in its earliest stage. Radiopharmaceuticals are also being used increasingly to treat disease as well as diagnose it. SPECT AND PET EXPLAINED SPECT (single-photon emission computed tomography) uses radioactive substances injected into the blood to create 3D images that help to diagnose a variety of diseases across oncology, cardiology, and neurology, among others. Like SPECT, PET (positron emission tomography) is a nuclear imaging technique that uses radioactive material placed in the body to create 3D images. However, PET imaging typically provides better resolutions.